{
    "Title": "A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia",
    "URL": "https://doi.org/10.1371/journal.pntd.0006653",
    "Published": "July 25, 2018",
    "Subject_Areas": [
        "Leishmaniasis",
        "Ulcers",
        "Drug therapy",
        "Lesions",
        "Leishmania",
        "Adverse events",
        "Colombia",
        "Parasitic diseases"
    ],
    "Authors": {
        "Liliana López": [
            "PECET—Programa de Estudio y Control de Enfermedades Tropicales, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia"
        ],
        "Iván Vélez": [
            "PECET—Programa de Estudio y Control de Enfermedades Tropicales, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia"
        ],
        "Claudia Asela": [
            "PECET—Programa de Estudio y Control de Enfermedades Tropicales, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia"
        ],
        "Claudia Cruz": [
            "Dirección de Sanidad, DISAN, Colombian Army, Bogotá, Colombia"
        ],
        "Fabiana Alves": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Sara Robledo": [
            "PECET—Programa de Estudio y Control de Enfermedades Tropicales, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia"
        ],
        "Byron Arana": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ]
    }
}